We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Helps Patients with Risk of Heart Disease

By LabMedica International staff writers
Posted on 28 Mar 2013
A simple screening blood test and management program can be effective in preventing heart failure for at-risk patients.

Blood levels of B-type natriuretic peptide (BNP), a hormone that indicates how well the heart is functioning and elevated BNP levels can indicate established heart failure.

Cardiologists at St. More...
Vincent's University Hospital (Dublin, Ireland) recruited 1,374 patients from 39 family practices as part of a five-year study. The participants were asymptomatic patients over 40 years of age with risk factors for heart failure and randomized into an intervention and a control group. Patients in the intervention group were screened for blood levels of BNP, at least annually and all patients were screened for cardiovascular risk factors.

Of the patients in the intervention group, 41.6% showed elevated BNP levels at some point during the study. These patients received an echocardiogram and continued care under both their physicians and a specialist cardiology service. In addition to showing lower rates of the primary endpoint, intervention patients also had lower rates of emergency hospitalization for major cardiovascular events at 22.3 per 1,000 patient years compared to 40.4 per 1,000 patient years in the control group. The investigators found that a significantly lower number of patients in the intervention group than in the control group met the primary endpoint of new onset heart failure requiring hospitalization or left ventricular dysfunction.

Kenneth McDonald, MD, director of the Heart Failure Unit at St. Vincent's and a senior author of the study, said "Our study shows that a simple blood test screening, followed by targeted care of people at heightened risk of heart failure, can result in a dramatic reduction in cardiovascular events. This is good news, since heart failure has become a major public health problem and middle-aged adults today have a 20% to 30% lifetime risk of developing heart failure." The study was presented at the American College of Cardiology's 62nd Annual Scientific Session held March 9–11, 2013, in San Francisco (CA, USA).

Related Links:
St. Vincent's University Hospital



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Collection and Transport System
PurSafe Plus®
Alcohol Testing Device
Dräger Alcotest 7000
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.